British Medical Association
Durbin PLC becomes Uniphar, bolstering medicine access amidst growing healthcare demands
Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address industry-wide challenges, expanding its sourcing...
Incyte Biosciences UK announces NICE approval for Opzelura for vitiligo
This is the first approved treatment option in the UK for patients with non-segmental vitiligo
UK and US agree on landmark pharma pricing tariff deal
US tariffs on UK-produced pharmaceuticals will remain at zero for three years
ViiV Healthcare receives NICE recommendation for HIV prevention therapy
The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales
New National Commission launched to strengthen AI regulation
The Commission will unite healthcare leaders, regulators and technology experts to shape future AI governance
NHS programme to give head and neck cancer patients fast-track access to mRNA vaccine
More than 11,000 people are diagnosed with head and neck cancers every year in England
NICE recommends BeOne’s Brukinsa to treat mantle cell lymphoma on NHS
Approximately 600 people are affected by the form of non-Hodgkin lymphoma every year in the UK
UK government publishes 10 Year Health Plan for England to ‘reinvent’ NHS
The plan’s three overarching themes are hospital to community, analogue to digital and sickness to prevention
NHS patients to access Theramex’s endometriosis pill following NICE recommendation
The once-a-day drug has been recommended for patients with a history of previous medical or surgical treatment
NHS programme to give melanoma patients fast-track access to skin cancer vaccine
The phase 2 study will evaluate Scancell's iSCIB1+ in patients with advanced unresectable melanoma
Prime minister unveils UK government’s plans to abolish NHS England
The move aims to cut waiting times and free up money for front-line services
World Kidney Day – Boehringer launches CKD initiative to tackle UK health inequalities
Approximately 10% of the UK population is affected by chronic kidney disease